EUROAPI

🚀 EUROAPI at #DCATWeek 2025: Strengthening Partnerships & Breaking Records! We were thrilled to participate in #DCATWeek, engaging in insightful discussions and strengthening key partnerships. As our CEO David Seignolle highlighted: “This week was very much around our customers and we can best serve them. I am very proud of the team result of hosting a record high number of meetings! So many customers are very enthusiastic and interested into our capabilities, driving exciting CDMO prospects ; especially our Peptides and Oligonucleotides platform.” A huge thank you to everyone who visited us, exchanged ideas, and showed interest in our expertise! 💊 #DCATWeek #CDMO #apisolutions

#DCATWeek is in full swing! 🤝 Feel free to drop by anytime in our Suites 5208 and 5217 - Lotte New York Palace.  #apisolutions #CDMO  

[#ESG] – #GlobalRecyclingDay ♻ Discover a few of EUROAPI’s recycling efforts to reduce the impact on our planet!   EUROAPI and its employees work every day on reducing waste, promoting sustainable practices and highlighting the benefits of #recycling and reusing: ✅ A Responsible Innovation Program was launched to boost environmentally friendly projects, such as setting up a recycling process for several compounds ✅ 70+% of our solvents are recycled ✅ At our industrial sites, we clean and reuse plastic drums: ~10,000 drums saved and reused at our Vertolaye site in France and 1,800 drums at our Budapest site.   Find out more about our ESG commitments ➡https://lnkd.in/gmh4CkFu 🌿 #AchievingTogether. Join us on this Recycling journey!

Critical Medicines Act, une avancée prometteuse mais encore trop timide ! 💊 Sur les médicaments critiques, l’autonomie stratégique de l’Europe doit être assumée, chiffrée et objectivée. Lien vers le texte du CMA : https://bit.ly/4iqtjYa

[#NextGenBiomed2025] 🙏 Thanks for attending the EUROAPI session about ‘#Peptides in various combinations of drug modalities’ presented by Kerstin Jahn-Hofmann and Mark Macdonald. If you missed the presentation or if you have any questions, do not hesitate to reach out to us. Our experts will be more than happy to provide you with detailed information about our #tide capabilities: 👉 contact@euroapi.com 👉 https://lnkd.in/ebtyCefs #cdmo #oligonucleotides

EUROAPI is excited to announce that we will attend #CPHIJapan2025 - April 9-11 (Tokyo Big Sight, Japan). 🤝 Don’t miss the chance to connect with our team! Stop by our Booth #5P-10. The EUROAPI team will be delighted to introduce our API portfolio and our #CDMO capabilities to you. 📧 To schedule a meeting with our team: 👉 contact@euroapi.com 👉 https://lnkd.in/ebtyCefs Let’s discuss your projects! #apisolutions #activepharmaceuticalingredients

#NextGenBiomed2025 is now open!   🤝 Come and meet us in London (March 12-14). The EUROAPI team is looking forward to welcoming you to our stand #42.   📅 And don’t miss our presentation about ‘#Peptides in various combinations of drug modalities’ on March 14th at 14:15 (conference room 5).   See you soon!   #cdmo #tides #oligonucleotides

[📄 #Article]: API supply chain resilience by design   In the March/April issue of #SpecialityChemicalsMagazine, Didier Combis, Head of marketing & commercial development at EUROAPI, looks at why considering the API value chain can strengthen the global medicine #supplychain.   “Where the strategy of buying each chemical at the lowest possible cost, anywhere in the world, can effectively reduce costs in the short term, the consequential supply chain weakness is a dangerous strategy in the long term for many established APIs,” Didier Combis writes. “Strategic sourcing and procurement teams should therefore take a value chain perspective and consider the integration level among their supplier as a key long-term driver for value creation and supply line robustness.”   Read the full article 👉 https://lnkd.in/eysRiAA5   Discover EUROAPI’s API solutions 👉 https://lnkd.in/e5YX387w   #apisolutions #apisupplychain #activepharmaceuticalingredients

🔎 Focus on our #CDMO activities: EUROAPI’s expertise in #oligonucleotide project phases from early drug development to commercial production   Accelerate your drug development with our high-quality, GMP-compliant oligonucleotide synthesis services including: ✔State-of-the-art facilities ✔Scalable production from small to large batches ✔Extensive modification and conjugation options (ASO, siRNA, CRISPR guide RNA) ✔Agile and flexible processes optimized for early-phase development ✔Seamless transition from early development to clinical and commercial phases   By coupling EUROAPI BianoGMP GmbH’s expertise and capacity in early-stage projects with EUROAPI’s larger scale capabilities in Frankfurt, we aim to support our clients along the drug development pathway as a one-stop shop.   Read more ➡ https://lnkd.in/gmHVMZXm   📧 Feel free to contact our technical experts to discuss your project: 👉 contact@euroapi.com 👉 https://lnkd.in/ebtyCefs 👉 you can also post your request on https://lnkd.in/eSgqrkj6     #tides #activepharmaceuticalingredients

📢 EUROAPI est au #VillagedelaChimie   Venez rencontrer nos équipes ! Nous vous accueillons sur le stand E10.   Nos collaborateurs seront ravis de vous présenter nos activités, notre R&D ainsi que les différents métiers de nos sites industriels, en France et en Europe. Posez-leur vos questions et discutez avec eux pour découvrir les métiers de la #chimie appliquée à l’industrie #pharmaceutique.   🕗 Vendredi 7 mars : 9h à 17h Samedi 8 mars : 10h à 17h 📍 #ParcFloraldeParis, Route de la Pyramide, 75012 Paris Nous avons hâte de vous rencontrer !